Evidence map›Paper›PMID 39103430›Full record

ArticleScientific reports2024

MCM-41 supported 2-aminothiophenol/Cu complex as a sustainable nanocatalyst for Suzuki coupling reaction.

Sepideh Bibak, Ahmad Poursattar Marjani, Hamideh Sarreshtehdar Aslaheh

RetractedAbstract readRetracted Publication
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sepideh BibakDepartment of Organic Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran.ORCID http://orcid.org/0000-0002-0636-6201
Ahmad Poursattar MarjaniDepartment of Organic Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran. a.poursattar@urmia.ac.ir.ORCID http://orcid.org/0000-0002-5899-4285
Hamideh Sarreshtehdar AslahehDepartment of Organic Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran.ORCID http://orcid.org/0000-0002-8316-1648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have developed an innovative mesoporous nanocatalyst by carefully attaching a 2-aminothiophenol-Cu complex onto functionalized MCM-41. This straightforward synthesis process has yielded a versatile nanocatalyst known for its outstanding efficiency, recyclability, and enhanced stability. The structural integrity of the nanocatalyst was comprehensively analyzed using an array of techniques, including BET (Brunauer-Emmett-Teller) for surface area measurement, ICP (Inductively Coupled Plasma) for metal content determination, EDS (Energy-Dispersive X-ray Spectroscopy) for elemental mapping, XRD (X-ray Diffraction) for crystalline structure elucidation, SEM (Scanning Electron Microscopy), EMA (Elemental Mapping Analysis), TEM (Transmission Electron Microscopy), TGA (Thermogravimetric Analysis), FT-IR (Fourier Transform Infrared Spectroscopy), AFM (Atomic Force Microscopy), and CV (cyclic voltammetry). Subsequently, the catalytic properties of the newly developed MCM-41-CPTEO-2-aminothiophenol-Cu catalyst was evaluated in the synthesis of biphenyls, demonstrating outstanding yields through a Suzuki coupling reaction between phenylboronic acid and aryl halides. Importantly, this reaction was conducted in an environmentally friendly medium. Note the remarkable recyclability of the catalyst, proving its sustainability over six cycles with minimal loss in activity additionally hot filtration test was prepared to examine the stability of this nanocatalyst. This outstanding feature emphasizes the catalyst's potential for long-term, environmentally conscious catalytic applications.

Indexed as

2-Aminothiophenol-CuHeterogeneous nanocatalystMCM-41Suzuki reaction

Identifiers

PMID39103430
PMCPMC11300451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.